A Study to Learn About How a New Pneumococcal Vaccine Works in Infants

Clinical trial NCT06524414 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06524414
Sponsor: Pfizer
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pneumococcal Disease

Start date: 2024-07-25
Primary completion: 2027-05-01
Enrollment: 605

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.